Clinical Trials Browser

Phase 1/2 × IRX 2 × Gastrointestinal × Clear all

NCT03918499 2023-03-23

IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer

Phase 1/2 Completed

9 enrolled 9 charts

Gastrointestinal

Clinical Stage IV Gastric Cancer AJCC v8